297 related articles for article (PubMed ID: 2435295)
1. Prevention and treatment of Epstein-Barr virus (EBV)-associated lymphoproliferative diseases in immune deficient patients.
Purtilo DT
AIDS Res; 1986 Dec; 2 Suppl 1():S177-81. PubMed ID: 2435295
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin class and subclass deficiencies prior to Epstein-Barr virus infection in males with X-linked lymphoproliferative disease.
Grierson HL; Skare J; Hawk J; Pauza M; Purtilo DT
Am J Med Genet; 1991 Sep; 40(3):294-7. PubMed ID: 1683154
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus (EBV) and X-linked lymphoproliferative syndrome (XLP).
Tatsumi E; Purtilo DT
AIDS Res; 1986 Dec; 2 Suppl 1():S109-13. PubMed ID: 3030340
[TBL] [Abstract][Full Text] [Related]
4. X-linked lymphoproliferative syndrome.
Sullivan JL; Woda BA
Immunodefic Rev; 1989; 1(4):325-47. PubMed ID: 2561059
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus-induced diseases in the X-linked lymphoproliferative syndrome and related disorders.
Purtilo DT
Biomed Pharmacother; 1985; 39(2):52-8. PubMed ID: 2990590
[TBL] [Abstract][Full Text] [Related]
6. Cellular immune defects to Epstein-Barr virus-determined antigens in young males.
Masucci MG; Szigeti R; Ernberg I; Masucci G; Klein G; Chessels J; Sieff C; Lie S; Glomstein A; Businco L; Henle W; Henle G; Pearson G; Sakamoto K; Purtilo DT
Cancer Res; 1981 Nov; 41(11 Pt 1):4284-91. PubMed ID: 6171337
[TBL] [Abstract][Full Text] [Related]
7. Necrotizing lymphoid vasculitis in X-linked lymphoproliferative syndrome.
Loeffel S; Chang CH; Heyn R; Harada S; Lipscomb H; Sinangil F; Volsky DJ; McClain K; Ochs H; Purtilo DT
Arch Pathol Lab Med; 1985 Jun; 109(6):546-50. PubMed ID: 2986573
[TBL] [Abstract][Full Text] [Related]
8. X-linked lymphoproliferative syndrome provides clues to the pathogenesis of Epstein-Barr virus-induced lymphomagenesis.
Purtilo DT; Yasuda N; Grierson HL; Okano M; Brichacek B; Davis J
Princess Takamatsu Symp; 1987; 18():149-58. PubMed ID: 2852188
[TBL] [Abstract][Full Text] [Related]
9. Immunodeficiency as a factor in lymphomagenesis.
Purtilo DT; Sakamoto K
Perspect Pediatr Pathol; 1984; 8(2):181-91. PubMed ID: 6330665
[TBL] [Abstract][Full Text] [Related]
10. X-linked lymphoproliferative syndrome. An immunodeficiency disorder with acquired agammaglobulinemia, fatal infectious mononucleosis, or malignant lymphoma.
Purtilo DT
Arch Pathol Lab Med; 1981 Mar; 105(3):119-21. PubMed ID: 6894075
[TBL] [Abstract][Full Text] [Related]
11. Malignant B-cell lymphoma following and associated with infectious mononucleosis. A comparison of two cases.
Pattengale PK; Taylor CR; Pegalow C
Am J Pediatr Hematol Oncol; 1981; 3(1):35-42. PubMed ID: 6263125
[TBL] [Abstract][Full Text] [Related]
12. Immune deficiency in the X-linked lymphoproliferative syndrome. I. Epstein-Barr virus-specific defects.
Harada S; Sakamoto K; Seeley JK; Lindsten T; Bechtold T; Yetz J; Rogers G; Pearson G; Purtilo DT
J Immunol; 1982 Dec; 129(6):2532-5. PubMed ID: 6292290
[TBL] [Abstract][Full Text] [Related]
13. [X-chromosomal recessively inherited lymphoproliferative syndrome. An analysis of EBV-induced immune deficiency].
Kammermeier-Schmidt U; Weiss M; Belohradsky BH
Monatsschr Kinderheilkd; 1993 Mar; 141(3):201-6. PubMed ID: 8386321
[TBL] [Abstract][Full Text] [Related]
14. Management of Epstein-Barr virus infections.
Andersson J; Ernberg I
Am J Med; 1988 Aug; 85(2A):107-15. PubMed ID: 2841854
[TBL] [Abstract][Full Text] [Related]
15. [Cutaneous and neurologic vasculitis disclosing EBV-selective immunodeficiency].
Grosieux C; Amoric JC; Mechinaud F; Moreau A; Mussini JM; Fesneau H; Dreno B; Bureau B; Stalder JF; Litoux P
Ann Dermatol Venereol; 1996; 123(6-7):387-92. PubMed ID: 8959062
[TBL] [Abstract][Full Text] [Related]
16. Lymphotropic viruses, Epstein-Barr virus (EBV) and human T-cell lymphotropic virus-I (HTLV-I)/adult T-cell leukemia virus (ATLV), and HTLV-III/human immune deficiency virus (HIV) as etiological agents of malignant lymphoma and immune deficiency.
Purtilo DT
AIDS Res; 1986 Dec; 2 Suppl 1():S1-6. PubMed ID: 2881552
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of families wherein a single male manifests a phenotype of X-linked lymphoproliferative disease (XLP).
Grierson HL; Skare J; Church J; Silberman T; Davis JR; Kobrinsky N; McGregor R; Israels S; McCarty J; Andrews LG
Am J Med Genet; 1993 Sep; 47(4):458-63. PubMed ID: 8256804
[TBL] [Abstract][Full Text] [Related]
18. Clinical aspects on Epstein-Barr virus infection.
Andersson JP
Scand J Infect Dis Suppl; 1991; 80():94-104. PubMed ID: 1666450
[TBL] [Abstract][Full Text] [Related]
19. X-linked lymphoproliferative syndrome presenting with systemic lymphocytic vasculitis.
Kanegane H; Ito Y; Ohshima K; Shichijo T; Tomimasu K; Nomura K; Futatani T; Sumazaki R; Miyawaki T
Am J Hematol; 2005 Feb; 78(2):130-3. PubMed ID: 15682426
[TBL] [Abstract][Full Text] [Related]
20. Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by clinical, virological, and immunopathological studies.
Purtilo DT; Sakamoto K; Saemundsen AK; Sullivan JL; Synnerholm AC; Anvret M; Pritchard J; Sloper C; Sieff C; Pincott J; Pachman L; Rich K; Cruzi F; Cornet JA; Collins R; Barnes N; Knight J; Sandstedt B; Klein G
Cancer Res; 1981 Nov; 41(11 Pt 1):4226-36. PubMed ID: 6272967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]